Last
Update:
April 19, 2018
Documents identified with this
icon are in Portable Document Format (PDF) and require the
Adobe
Acrobat Reader
Journal Papers, Abstracts, and Commentaries
| |
.Cytomegalovirus antibody and vascular pathology in renal
transplant recipients.
Price P, Lee S, Affandi J,
et al
J Med Virol. 2017
Jan;89(1):177-181.
Abstract
Correlation between CMV Infection and Post-transplantation
New-onset Diabetes Mellitus.
Dedinská I, Laca Ľ, Mikluica J,
Int J Organ Transplant Med.
2016;7(3):173-182.
Abstract
Recurrence of CMV Infection and the Effect of Prolonged
Antivirals in Organ Transplant Recipients.
Natori Y, Humar A, Husain S, et al
Transplantation. 2016 Jul 27
Abstract
Cytomegalovirus Scrotal Ulcer in a Renal Transplant Patient.
Pinca R, Crawford RI, Au S.
J Cutan Med Surg. 2016 May 18. pii: 1203475416650643
Abstract
Clinical utility of cytomegalovirus viral load in solid organ
transplant recipients.
Dioverti MV, Razonable RR.
Curr Opin Infect Dis. 2015
Aug;28(4):317-22.
Abstract
Approach to drug-resistant cytomegalovirus in transplant recipients.
Chou S.
Curr Opin Infect Dis. 2015 Aug;28(4):293-9.
Abstract
Influence of IFNL3/4 polymorphisms on the
incidence of cytomegalovirus infection after solid-organ
transplantation.
Manuel O, Wójtowicz A, Bibert S, Mueller NJ, et al
J Infect Dis. 2014 Oct 9.
Abstract
Influence of IFNL3/4 polymorphisms on the
incidence of cytomegalovirus infection after solid-organ transplantation.
Manuel O, Wójtowicz A, Bibert S, Mueller NJ, et al
J Infect Dis. 2014 Oct 9.
Abstract
\A Direct and Indirect Comparison Meta-analysis on the Efficacy of
Cytomegalovirus Preventive Strategies in Solid Organ Transplantation.
Florescu DF, Qiu F, Schmidt CM, Kalil AC.
Clin Infect Dis.
2014 Jan
Abstract
KIR and HLA interactions are associated with control of
primary CMV infection in solid organ transplant recipients.
van Duin D, Avery RK, Hemachandra S, . et al
Am J Transplant. 2014
Jan;14(1):156-62.
Abstract
Assessment of cytomegalovirus specific cell-mediated
immunity for the prediction of cytomegalovirus disease in
high-risk solid-organ transplant recipients: a multicenter
cohort study.
Manuel O, Husain S, Kumar D, et al
Clin Infect Dis. 2012 Nov 29.
Abstract
FULL-TEXT ARTICLE
An Analysis of Regulatory T-Cell and Th-17 Cell Dynamics
during Cytomegalovirus
Replication in Solid Organ Transplant Recipients.
Egli A, Silva M Jr, O'Shea D,
et al
PLoS One.
2012;7(11):e43937.
Paper
Clinical Predictors of Relapse after Treatment of Primary Gastrointestinal
Cytomegalovirus Disease in Solid Organ Transplant Recipients.
Eid AJ, Arthurs SK, Deziel PJ, et al
Am J Transplant. 2009 Nov 4
Abstract |
|
|
|
|
|
|
|
Journal Papers, Abstracts, and Commentaries
| |
Cytomegalovirus pre-emptive therapy after
hematopoietic stem cell transplantation in the era of real-time
quantitative PCR; comparison with recipients of solid organ
transplants.
Panagou E, Zakout G, Keshani J,
et al
Transpl Infect Dis. 2016 Apr 8.
FULL-TEXT ARTICLE
Two strategies for prevention of
cytomegalovirus infections after liver
transplantation.
Simon P, Sasse M, Laudi S, et al
World J Gastroenterol.
2016 Mar 28;22(12):3412-7.
Paper
Prophylaxis versus pre-emptive treatment for
prevention of cytomegalovirus infection in
CMV-seropositive orthotopic liver-transplant recipients.
Mengelle C, Rostaing L, Weclawiak H, et al
J Med Virol. 2015 Feb 5.
Abstract
Universal Prophylaxis or Preemptive Strategy for
Cytomegalovirus Disease After Liver Transplantation: A
Systematic Review and Meta-Analysis.
Mumtaz K, Faisal N, Husain S,
wt al
Am J Transplant.
2014 Dec 17.
Abstract
Cost of prophylaxis in the management of cytomegalovirus infection in
solid organ transplant
recipients.
Oppenheimer F, Gonzalez-Molina M, Rubio M.
Clin Transplant. 2007
Jul-Aug;21(4):441-8.
Abstract
|
Antiviral dosing and efficacy for prophylaxis of cytomegalovirus disease
in solid organ
transplant recipients.
Cochrane AB.
Am J Health Syst
Pharm. 2006 Oct 1;63(19 Suppl
Abstract
|
Journal Papers, Abstracts, and Commentaries
| |
Incidence, risk factors, and outcomes of delayed-onset
cytomegalovirus disease in a large, retrospective cohort of heart transplant
recipients.
Santos CA, Brennan DC, Fraser VJ, Olsen MA
Transplant Proc. 2014 Dec;46(10):3585-92
Abstract
Does the calcineurin inhibitor have influence on
cytomegalovirus infection in heart transplantation?
Rodríguez-Serrano M, Sánchez-Lázaro I, Almenar-Bonet L, et al
Clin Transplant. 2013 Dec 11.
Abstract
Repeated CMV infection in a heart transplantation patient.
Melero-Ferrer J, Sanchez-Lazaro IJ, Navea-Tejerina A,. et al
Case Rep Transplant.
2012;2012:305920.
Abstract
Lower incidence of cytomegalovirus infection with everolimus versus
mycophenolate mofetil
in de novo cardiac transplant recipients: a randomized, multicenter study.
Viganň M, Dengler T, Mattei MF, et al
Transpl Infect Dis. 2009 Sep
Abstract |
High incidence of cytomegalovirus disease in D+/R- heart transplant
recipients shortly after
completion of 3 months of valganciclovir prophylaxis.
Gupta S, Mitchell JD, Markham DW, et al
J Heart Lung Transplant. 2008
May;27(5):536-9.
Abstract
|
Cytomegalovirus infection in heart transplant recipients is
associated with impaired
endothelial function.
Petrakopoulou P, Kubrich M, Pehlivanli S, et al
Circulation. 2004 Sep
14;110(11 Suppl 1):II207-12.
Abstract |
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
| |
Cytomegalovirus infection in living donor liver transplant
recipients significantly impacts the early post-transplant
outcome: A single center experience.
Yadav SK, Saigal S, Choudhary NS, et al
Transpl Infect Dis. 2018 Apr 18:e12905
Abstract
Cytomegalovirus Infection in Liver Transplant Recipients:
Current Approach to Diagnosis and Management.
Yadav SK, Saigal S, Choudhary N
J Clin Exp Hepatol.
2017 Jun;7(2):144-151
Abstract
Universal Prophylaxis or Preemptive Strategy for
Cytomegalovirus Disease After Liver Transplantation: A
Systematic Review and Meta-Analysis.
Mumtaz K, Faisal N, Husain S,
wt al
Am J Transplant.
2014 Dec 17.
Abstract
Antiviral prophylaxis versus preemptive therapy to prevent
cytomegalovirus infection and related death in liver transplantation: a
retrospective study with propensity score matching.
Kim SI, Kim CJ, Kim YJ,
et al
Transplant Proc. 2012
Apr;44(3):787-90
Abstract
|
|
|
|
Journal Papers, Abstracts, and Commentaries
|
| |
Cytomegalovirus infection alters phenotypes of different γδ
T-cell subsets in renal transplant recipients with long-term
stable graft function.
Lee S, Affandi JS, Irish AB, Price P. et al
J
Med Virol. 2017 Feb 15.
Abstract
Incidence and Risk Factors for
Cytomegalovirus Infection in Patients With Kidney
Transplantation: A Single-Center Experience.
Feng S, Yang J, Wang W, et al
Transplant Proc.
2016 Oct;48(8):2695-2699.
Abstract
Reduced Incidence of Cytomegalovirus
Infection in Kidney Transplant Recipients Receiving
Everolimus and Reduced Tacrolimus Doses.
Tedesco-Silva H, Felipe C, Ferreira A, et al
Am J Transplant.
2015 May 18.
Abstract
Reduced Rate of Cardiovascular Death After Cytomegalovirus
Prophylaxis in Renal Transplant Recipients.
Opelz G, Döhler B.
Transplantation. 2015 Jan 20.
Abstract
VZV encephalitis following successful
treatment of CMV infection in a patient with kidney
transplant.
Nabi S, Kahlon P, Goggins M, Patel A.
BMJ Case Rep. 2014 Dec 2;2014. pii:
bcr2014206655.
Abstract
Cytomegalovirus glomerulopathy and
cytomegalovirus interstitial nephritis on sequential
transplant kidney biopsies.
Vichot AA, Formica RN Jr, Moeckel GW.
Am J Kidney Dis. 2014
Mar;63(3):536-9.
Abstract
Risk Factors for Late-Onset Cytomegalovirus
Infection or Disease in Kidney Transplant Recipients.
Jamal AJ, Husain S, Li Y, et al
Transplantation.
2014 Jan 6.
Abstract
The impact of early cytomegalovirus infection after kidney
transplantation on long-term graft and patient survival.
Smedbrĺten YV, Sagedal S, Leivestad T, et al
Clin Transplant.
2013 Dec 18.
Abstract
Pretransplant CD8 T-Cell Response to IE-1
Discriminates Seropositive Kidney Recipients at Risk of
Developing CMV Infection Posttransplant.
López-Oliva MO, Martinez V, Buitrago A,
et al
Transplantation.
2013 Dec 16.
Abstract
Impaired Direct Priming of CD8 T Cells by
Donor-Derived Cytomegalovirus Following Kidney
Transplantation.
Shabir S, Kaul B, Pachnio A, et al
J
Am Soc Nephrol.
2013 Jul 11
Abstract
Cytomegalovirus polyradiculopathy of late
onset in a young renal transplant recipient.
Papasotiriou M, Papachristou E, Marangos M, et al
Clin Nephrol. 2013
Jul;80(1):75-8.
Abstract
Cytomegalovirus disease in kidney transplant
recipients: incidence, clinical profile, and risk factors.
Cordero E, Casasola C, Ecarma R, Danguilan R.
Transplant Proc.
2012 Apr;44(3):694-700
Abstract
Spectrum of cytomegalovirus-induced renal
pathology in renal allograft recipients.
Rane S, Nada R, Minz M, et al
Transplant Proc. 2012 Apr;44(3):713-6
Abstract
Historical comparison of prophylactic
ganciclovir for gastrointestinal cytomegalovirus infection
in kidney transplant recipients.
Kim HC, Hwang EA, Park SB,
et al
Transplant Proc. 2012
Apr;44(3):710-2.
Abstract
Cytomegalovirus viremia after kidney
transplantation in Thailand: predictors of symptomatic
infection and outcome
Watcharananan SP, Louhapanswat S, Chantratita W,
et
al
Transplant Proc.
2012 Apr;44(3):701-5.
Abstract |
|
|
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
| |
Treatment of CMV Infection after Allogeneic Hematopoietic Stem
Cell Transplantation.
Maffini E, Giaccone L, Festuccia M,
et al
Expert Rev Hematol. 2016 Apr 4. [
Abstract
Prospective surveillance vs clinically driven approach for CMV
reactivation after autologous stem cell transplant.
Mengarelli A, Annibali O, Pimpinelli F,
et al
J Infect. 2015 Dec
11
Abstract
Favorable outcome
of haploidentical hematopoietic stem cell transplantation in
Philadelphia chromosome-positive acute lymphoblastic leukemia: a
multicenter study in Southwest China.
Gao L, Zhang C, Gao L,
et al
J Hematol Oncol.
2015 Jul 26;8(1):90.
Abstract
Characterisation of CMV-specific
CD4+ T-cell reconstitution following
stem cell transplantation through the
use of HLA Class II-peptide tetramers
identifies patients at high risk of
recurrent CMV reactivation.
Raeiszadeh M,
Pachnio A, Begum J, et al
Haematologica. 2015 May 14.
Abstract
Cytomegalovirus reactivation following hematopoietic stem
cell transplantation.
Sharma SK, Kumar S, Agrawal N,
et al
J Infect Dev Ctries. 2013 Dec
15;
Abstract
Diagnosis and treatment of CMV and EBV Reactivation as
well as Post-transplant Lymphoproliferative Disorders following
Allogeneic Stem Cell Transplantation: An SFGM-TC report.]
Bay JO, Peffault de Latour R, Bruno B, et al
Pathol Biol (Paris). 2013 Sep 3.
Abstract
Cytomegalovirus is a potential risk factor for late-onset
hemorrhagic cystitis following allogeneic hematopoietic stem cell
transplantation.
Han TT, Xu LP, Liu DH, et al
Am J Hematol. 2013
Sep 5.
Abstract
Cytomegalovirus (CMV) genotype in allogeneic
hematopoietic stem cell transplantation.
Dieamant DC, Bonon SH, Peres RM, et al
BMC Infect Dis.
2013 Jul 10;13(1):310
Abstract |
|
|
|
|
|
|
General
Reports
CMV
Main Page
Main
New/Newsworthy
